Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Medrad to purchase Pathway Medical

Medrad, a unit of Bayer Healthcare, is set to purchase Pathway Medical Technologies for $125m.

The deal also includes a bonus of $6.3m to retain certain members of Pathway’s senior management team, Xconomy reported.

Pathway is a maker of a device that clears out blood vessel blockages in the legs.

Pathway’s Jetstream uses a tiny stainless-steel drill mounted on a catheter that slides inside clogged leg arteries, where it cuts through and vacuums out hard plaque blockages and squishier clot-like substances.

The deal is still pending, awaiting final regulatory and shareholder approval.